SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001048477-24-000132
Filing Date
2024-08-28
Accepted
2024-08-28 17:02:40
Documents
13
Period of Report
2024-08-23
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20240823.htm   iXBRL 8-K 24191
  Complete submission text file 0001048477-24-000132.txt   148793

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20240823.xsd EX-101.SCH 2001
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20240823_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20240823_pre.xml EX-101.PRE 12603
15 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20240823_htm.xml XML 2712
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 241256500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)